Bulletin
Investor Alert

Cassava Sciences Inc.

NAS: SAVA

GO
/marketstate/country/us

After Hours

/zigman2/quotes/204212356/composite

$

39.50

Change

+0.05 +0.13%

Volume

Volume 20,498

Jan 26, 2022, 7:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/204212356/composite

Previous close

$ 40.02

$ 39.45

Change

-0.57 -1.42%

Day low

Day high

$38.32

$41.49

Open
Open: 41.00

52 week low

52 week high

$17.15

$146.16

Open

Market cap

$1.60B

Average volume

3.33M

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-0.55

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/sava

MarketWatch News on SAVA

  1. Cassava Sciences stock drops 6.7% premarket, after plunging 59.0% over the past 3 weeks

    7:26 a.m. Sept. 7, 2021

    - Tomi Kilgore

  2. Cassava Sciences stock price target cut to $108 from $145 at B. Riley

    7:23 a.m. Sept. 7, 2021

    - Tomi Kilgore

  3. Cassava Sciences stock bounces 4.5% premarket, after plunging 31.4% on Wednesday

    7:44 a.m. Aug. 26, 2021

    - Tomi Kilgore

  4. Cassava Sciences stock price target raised to $145 from $111 at B. Riley

    6:58 a.m. Aug. 3, 2021

    - Tomi Kilgore

  5. Analyst Raises Price Targets on 3 Smaller Alzheimer's Stocks

    10:50 a.m. July 7, 2021

    - Barron's Online

  6. Cassave Sciences stock price target raised to $190 from $80 at Maxim Group

    7:30 a.m. July 7, 2021

    - Tomi Kilgore

  7. Cassava Sciences started at buy with $78 stock price target at B. Riley

    6:35 a.m. April 27, 2021

    - Tomi Kilgore

  8. The age of the ‘silver stoners’ is nigh

    7:32 a.m. March 20, 2021

    - Brett Arends

  9. Cassava Sciences stock price target raised to $80 from $14 at Maxim Group

    7:53 a.m. Feb. 16, 2021

    - Tomi Kilgore

  10. Treating the Causes, Not Symptoms, of Alzheimer’s

    9:30 p.m. Feb. 12, 2021

    - Barron's Online

  11. Cassava Sciences to offer $200 mln of shares priced at $49 each vs. $50.29 at Tuesday's close

    6:32 a.m. Feb. 10, 2021

    - Ciara Linnane

  12. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/sava

Other News on SAVA

  1. 6 Top Biotech Ideas For 2022

    9:28 a.m. Jan. 20, 2022

    - Seeking Alpha

  2. INmune Bio, The Biotech In My Stable For After Cassava Sciences

    11:23 a.m. Jan. 17, 2022

    - Seeking Alpha

  3. Cassava Sciences Has A High Probability Of Failure

    8:00 a.m. Jan. 12, 2022

    - Seeking Alpha

  4. Cassava Sciences: Credibility Issues

    4:15 p.m. Jan. 11, 2022

    - Seeking Alpha

  5. Where Will Cassava Sciences Be in 1 Year?

    7:22 a.m. Jan. 7, 2022

    - Motley Fool

  6. Cassava Sciences, Inc. - The Short Squeeze Has Started

    12:01 p.m. Jan. 6, 2022

    - Seeking Alpha

  7. 3 Healthcare Stocks That Could Rocket Higher in 2022

    11:30 a.m. Jan. 4, 2022

    - Motley Fool

  8. Loading more headlines...
/news/pressrelease/company/us/sava

Press Releases on SAVA

  1. Cassava Sciences Inc SAVA Proactive Strategies

    11:17 p.m. Jan. 20, 2022

    - Stock Traders Daily

  2. Cassava Sciences Inc SAVA Trading Report

    5:18 a.m. Jan. 11, 2022

    - Stock Traders Daily

  3. Cassava Sciences Inc (SAVA) Trading Report

    11:15 a.m. Jan. 1, 2022

    - Stock Traders Daily

  4. Cassava Sciences Inc SAVA Pivot Points

    3:40 p.m. Dec. 22, 2021

    - Stock Traders Daily

  5. Top Penny Stocks To Buy? 3 Former Stocks Under $5 To Watch Now

    10:45 a.m. Dec. 21, 2021

    - Penny Stocks

  6. Cassava Sciences Inc SAVA Investment Report

    6:54 p.m. Dec. 12, 2021

    - Stock Traders Daily

  7. Loading more headlines...

Rates »

Trending Tickers
  • /zigman2/quotes/207732364/composite MSFT-2.66%
  • /zigman2/quotes/203165245/composite T+0.53%
  • /zigman2/quotes/213120645/composite DKNG-3.54%
  • /zigman2/quotes/209901640/composite SPY-1.22%
  • /zigman2/quotes/209958550/composite AUPH+3.30%
X
Powered by StockTwits
Link to MarketWatch's Slice.